ATE248863T1 - Cyclodextrinderivate und verfahren zu deren herstellung - Google Patents

Cyclodextrinderivate und verfahren zu deren herstellung

Info

Publication number
ATE248863T1
ATE248863T1 AT95942008T AT95942008T ATE248863T1 AT E248863 T1 ATE248863 T1 AT E248863T1 AT 95942008 T AT95942008 T AT 95942008T AT 95942008 T AT95942008 T AT 95942008T AT E248863 T1 ATE248863 T1 AT E248863T1
Authority
AT
Austria
Prior art keywords
adjuvants
production
cyclodextrine derivatives
sulpholipid
polysaccharide
Prior art date
Application number
AT95942008T
Other languages
English (en)
Inventor
Luuk Hilgers
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3888560&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE248863(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Application granted granted Critical
Publication of ATE248863T1 publication Critical patent/ATE248863T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95942008T 1994-12-27 1995-12-21 Cyclodextrinderivate und verfahren zu deren herstellung ATE248863T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9401174A BE1008978A5 (fr) 1994-12-27 1994-12-27 Adjuvants pour vaccins.
PCT/BE1995/000120 WO1996020222A1 (en) 1994-12-27 1995-12-21 Novel cyclodextrin-derivatives and methods for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE248863T1 true ATE248863T1 (de) 2003-09-15

Family

ID=3888560

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95942007T ATE199644T1 (de) 1994-12-27 1995-12-21 Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffe
AT95942008T ATE248863T1 (de) 1994-12-27 1995-12-21 Cyclodextrinderivate und verfahren zu deren herstellung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT95942007T ATE199644T1 (de) 1994-12-27 1995-12-21 Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffe

Country Status (17)

Country Link
US (2) US6328965B1 (de)
EP (2) EP0814836B1 (de)
JP (2) JP4087900B2 (de)
CN (2) CN1109049C (de)
AT (2) ATE199644T1 (de)
AU (2) AU713997B2 (de)
BE (1) BE1008978A5 (de)
BR (2) BR9510263A (de)
CA (2) CA2208849C (de)
DE (2) DE69531699T2 (de)
DK (2) DK0800539T3 (de)
ES (2) ES2155540T3 (de)
GR (1) GR3035941T3 (de)
MX (1) MX9704822A (de)
PT (2) PT814836E (de)
SI (1) SI0800539T1 (de)
WO (2) WO1996020008A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5916883A (en) * 1996-11-01 1999-06-29 Poly-Med, Inc. Acylated cyclodextrin derivatives
CA2654522C (en) * 1997-08-29 2014-01-28 Antigenics Inc. Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as exipient
EP1104767A1 (de) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- und Disaccharidederivate die sowohl Fettsäureestern als Sulfatestern enthalten
AT408150B (de) * 2000-04-14 2001-09-25 Oesterr Forsch Seibersdorf Verfahren zur immobilisierung eines analyten an einer festen oberfläche
FR2808691B1 (fr) 2000-05-12 2005-06-24 Coletica Cyclodextrines substituees preferentiellement sur leur face primaire par des fonctions acide ou amine
FR2825714B1 (fr) * 2001-06-08 2005-03-25 Seppic Sa Nouvelle utilisation de complexes d'inclusion de cyclodestrine
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
EP1496916A2 (de) * 2002-04-09 2005-01-19 Greenville Hospital System Metastasen-modulierende wirkung von hochsulfierten oligosacchariden
WO2005037293A1 (en) * 2003-10-16 2005-04-28 Univ Monash Immunomodulating compositions and uses therefor
PT1954292E (pt) 2005-11-28 2014-08-04 Verrow Pharmaceuticals Inc Composições úteis para reduzir a nefrotoxicidade e métodos para a sua utilização
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
CN104043116A (zh) * 2007-11-06 2014-09-17 硕腾W有限责任公司 猪肺炎支原体无毒力佐剂化活疫苗
EP2062594A1 (de) 2007-11-21 2009-05-27 Wyeth Farma, S.A. Impfstoff und immunogene Zusammensetzung gegen den Blauzungenvirus, Verfahren zu deren Verwendung und Verfahren zu deren Herstellung
US8192721B2 (en) * 2007-12-13 2012-06-05 Verrow Pharmaceuticals, Inc. Compositions useful for reducing toxicity associated with gadolinium-based contrast agents
SA114350400B1 (ar) 2009-06-22 2016-05-26 ويث ال ال سي تركيبات وطرق لتحضير تركيبات مولدة للمناعة لمقترن بولي سكاريد كبسولي للنمط المصلي 5 و 8 من المكورات العنقودية الذهبية
CN102481352A (zh) 2009-06-22 2012-05-30 惠氏有限责任公司 金黄色葡萄球菌抗原的免疫原性组合物
US20110110980A1 (en) * 2009-09-02 2011-05-12 Wyeth Llc Heterlogous prime-boost immunization regimen
EP2397484A1 (de) 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharidderivate und ihre Verwendung als Adjuvantien
RU2580620C2 (ru) 2010-08-23 2016-04-10 ВАЙЕТ ЭлЭлСи СТАБИЛЬНЫЕ КОМПОЗИЦИИ АНТИГЕНОВ Neisseria meningitidis rLP2086
WO2012032489A1 (en) 2010-09-10 2012-03-15 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
CN101972477B (zh) * 2010-10-21 2012-09-26 中国医学科学院医学生物学研究所 磷酸锌疫苗佐剂
DK2654784T3 (en) 2010-12-22 2017-02-13 Wyeth Llc STABLE IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS ANTIGENES
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
CA2865745C (en) 2012-03-09 2018-01-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
ES2933127T3 (es) 2012-12-20 2023-02-01 Pfizer Procedimiento de glucoconjugación
US9802987B2 (en) 2013-03-08 2017-10-31 Pfizer Inc. Immunogenic fusion polypeptides
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
KR102319843B1 (ko) 2013-09-25 2021-10-29 조에티스 서비시즈 엘엘씨 Pcv2b 분지형 백신 조성물 및 사용 방법
CN104013955B (zh) * 2014-06-18 2016-02-24 中国科学院过程工程研究所 一种不含表面活性剂的水包油乳液及其用途
CN104086676B (zh) * 2014-07-18 2017-01-25 江苏省农业科学院 一种环糊精酯化衍生物、制备方法及其应用
HUE047467T2 (hu) 2014-07-24 2020-04-28 Litevax B V Adjuvánsok
AU2016221318B2 (en) 2015-02-19 2020-06-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
TWI807252B (zh) 2015-05-04 2023-07-01 美商輝瑞股份有限公司 Ｂ型鏈球菌多醣-蛋白質軛合物、製造軛合物之方法、含軛合物之免疫原性組成物、及其用途
US10751402B2 (en) 2016-11-09 2020-08-25 Pfizer Inc. Immunogenic compositions and uses thereof
US10183070B2 (en) 2017-01-31 2019-01-22 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
CN106928378A (zh) * 2017-03-29 2017-07-07 中国药科大学 一种十二酰基‑β‑环糊精的制备方法和用于色氨酸手性拆分的聚砜膜的制备方法
WO2019178601A1 (en) 2018-03-16 2019-09-19 Zoetis Services Llc Peptide vaccines against interleukin-31
WO2020048976A1 (en) 2018-09-04 2020-03-12 Ecole Polytechnique Federale De Lausanne (Epfl) Virucidal nanoparticles and use thereof against influenza virus
EP4034157A1 (de) 2019-09-27 2022-08-03 Pfizer Inc. Neisseria-meningitidis-zusammensetzungen und verfahren dafür
CA3192786A1 (en) 2020-08-26 2022-03-03 Pfizer Inc. Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
WO2026038177A1 (en) 2024-08-16 2026-02-19 Pfizer Inc. Immunogenic compositions and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565887A (en) * 1968-05-15 1971-02-23 Corn Products Co Unsaturated and long chain esters of cyclodextrin
US4247535A (en) * 1979-11-05 1981-01-27 American Cyanamid Company Modified cyclodextrin sulfate salts as complement inhibitors
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
EP0518930A4 (en) * 1990-03-02 1993-09-15 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications
FR2672496B3 (fr) * 1990-07-18 1993-05-28 Vacsyn France Sa Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
IT1242214B (it) * 1990-11-13 1994-03-03 Emo Chiellini Derivati polifunzionali delle ciclodestrine
JP2556236B2 (ja) * 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
ZA929870B (en) * 1991-12-23 1993-08-18 Duphar Int Res Adjuvants
WO1993017711A1 (en) * 1992-03-11 1993-09-16 Australian Commercial Research & Development Limited New cyclodextrins and new formulated drugs
DE4220734A1 (de) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Lipophile Cyclodextrinpolymere
US5464827A (en) * 1994-06-20 1995-11-07 American Home Products Corporation Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.

Also Published As

Publication number Publication date
CA2208790A1 (en) 1996-07-04
JP4087900B2 (ja) 2008-05-21
AU713997B2 (en) 1999-12-16
CA2208849C (en) 2006-10-10
BR9510223A (pt) 1997-12-30
ATE199644T1 (de) 2001-03-15
EP0800539A1 (de) 1997-10-15
EP0814836B1 (de) 2001-03-14
CN1109049C (zh) 2003-05-21
DE69531699T2 (de) 2004-07-08
CN1132630C (zh) 2003-12-31
US6328965B1 (en) 2001-12-11
DE69520376T2 (de) 2001-08-09
ES2155540T3 (es) 2001-05-16
MX9704822A (es) 1998-05-31
US6165995A (en) 2000-12-26
JPH10511997A (ja) 1998-11-17
ES2204969T3 (es) 2004-05-01
EP0814836A1 (de) 1998-01-07
DK0800539T3 (da) 2003-12-08
AU4324996A (en) 1996-07-19
CA2208790C (en) 2012-01-31
DE69531699D1 (de) 2003-10-09
AU709104B2 (en) 1999-08-19
CN1171052A (zh) 1998-01-21
BR9510263A (pt) 1997-11-04
EP0800539B1 (de) 2003-09-03
AU4324896A (en) 1996-07-19
MX9704824A (es) 1998-06-30
DK0814836T3 (da) 2001-04-17
SI0800539T1 (en) 2003-12-31
WO1996020008A1 (fr) 1996-07-04
PT800539E (pt) 2004-01-30
WO1996020222A1 (en) 1996-07-04
GR3035941T3 (en) 2001-08-31
DE69520376D1 (de) 2001-04-19
CN1175264A (zh) 1998-03-04
JPH11502192A (ja) 1999-02-23
PT814836E (pt) 2001-07-31
JP3927235B2 (ja) 2007-06-06
BE1008978A5 (fr) 1996-10-01
CA2208849A1 (en) 1996-07-04

Similar Documents

Publication Publication Date Title
DE69531699D1 (de) Cyclodextrinderivate und verfahren zu deren herstellung
MY129994A (en) Novel siloxane derivatives, producing method thereof and agents including siloxane derivative
NO932102D0 (no) Oligosakkarid avledet fra antigent polysakkarid erholdt fra et patogen
BR9611533A (pt) Lipopoliamina composição e utilização e processo de preparação de uma lipopoliamina
ATE232720T1 (de) Adjuvans für impfstoff
CY1108693T1 (el) Βελτιωμενες ανοσοενισχυτικες συνθεσεις σαπωνινης και μεθοδοι οι οποιες σχετιζονται με αυτες
FI905184A0 (fi) Kimeriska glykoproteiner som innehaoller immunogeniska delar av human parainfluensa-virus typ 3.
FI972054A0 (fi) Immunogeenisiä koostumuksia
BG96682A (bg) Метод за получаване на циклохексанови и тетрахидропиранови производни
DK0651609T3 (da) Pasteurella multocida toxoidvacciner
ES2119779T3 (es) Solubilizacion de proteinas en formas activas.
HUP9801917A2 (hu) Immunogén készítmény, eljárás annak előállítására és vakcinaként történő alkalmazására
ATE164313T1 (de) Inaktivierte respiratorische synzytial-virus- impfstoffe
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
ES2146279T3 (es) 1-ciclopropiltetrazolinonas herbicidas.
DE69331459D1 (de) Parenterale immunisierung gegen rotavirus
ATE267206T1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung
ATE177010T1 (de) Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie
IT9003466A0 (it) Metodo per la realizzazione di sedie, poltrone e simili strutture e profilato per l'attuazione di tale metodo.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0800539

Country of ref document: EP

EEIH Change in the person of patent owner